Although non-precedential, Aptalis Pharmatech, Inc. v. Apotex, Inc., Appeal No. 2017-1344 (Fed. Cir., January 4, 2018) provides a useful outline of Phillips-type claim construction and requires a close reading to see why the infringement finding by the district court was … Continue reading
The post Aptalis Fails to “Surround’ Apotex’s Generic ER Tablet appeared first on Patents4Life | Warren Woessner.